Natriuretic Peptide Receptor C Antibody - BSA Free

Western Blot: Natriuretic Peptide Receptor C Antibody - BSA Free [NBP1-31365] -

Modulation of Nprc expression by rosiglitazone and PPAR gamma.A, mRNA levels of Nprc and Fabp4 in 3T3-L1 adipocytes after treatment with 1 μM rosiglitazone (Rosi) or vehicle (Veh) for 6 h. B, mRNA levels of Nprc, Fabp4, and Ppar gamma 1/2 mRNA in 3T3-L1 adipocytes after siRNA knockdown of Ppar gamma (siPpar gamma ). C, protein levels of PPAR gamma 1/2, NPRC, FABP4, and ADIPOQ in 3T3-L1 adipocytes after siPpar gamma. D, mRNA levels of Nprc and Fabp4 in NIH-3T3 cells (NIH) and NIH-3T3 cells stably expressing PPAR gamma (NIH-PPAR gamma ) after treatment with 1 μM rosiglitazone (Rosi) or vehicle (Veh) for 6 h. Quantitative PCR data were normalized with 36B4. Student's t test, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001. Fabp4, fatty acid–binding protein 4; NIH, National Institutes of Health; Nprc, NP receptor C; ns, not significant; PPAR gamma, peroxisome proliferator–activated receptor gamma. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34245781), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: Natriuretic Peptide Receptor C Antibody - BSA Free [NBP1-31365] -

Nprc mRNA expression during 3T3-L1 adipocyte differentiation.A–C, mRNA levels of Nprc (A), Fabp4 (B), and Ppar gamma 1/2 (C) during 3T3-L1 adipocyte differentiation. Data were normalized with 36B4. D, protein levels of NPRC, FABP4, PPAR gamma 1/2, and ADIPOQ during 3T3-L1 adipocyte differentiation (Day 0, 2, 4, and 6). FABP4, fatty acid–binding protein 4; Nprc, NP receptor C; PPAR gamma 1/2, peroxisome proliferator–activated receptor gamma1/2. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34245781), licensed under a CC-BY license. Not internally tested by Novus Biologicals.